13 junio 2017

Market Research : Global Lung Cancer Therapeutics Market to contribute around $11.19 billion during the period 2017-2020 .

PM1183 - PharmaMar por supuesto ocupan un lugar en dicho informe ...

Albany, New York, June 13, 2017 :

Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two major types, namely NSCLC and SCLC. NSCLC is the commonest type of lung cancer and constitutes almost 85%-90% of the total diagnosed cases. It grows and spreads quite slowly.

Technavios analysts forecast the global lung cancer therapeutics market to contribute around $11.19 billion during the period 2016-2020.